Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 2500
118th Congress(2023-2024)
Protecting Americans from Unsafe Drugs Act of 2023
Introduced
Introduced
Introduced in House on Apr 6, 2023
Overview
Text
Introduced in House 
Apr 6, 2023
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Apr 6, 2023)
Apr 6, 2023
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 2500 (Introduced-in-House)


118th CONGRESS
1st Session
H. R. 2500


To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

April 6, 2023

Mr. Kim of New Jersey introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protecting Americans from Unsafe Drugs Act of 2023”.

SEC. 2. Notification, nondistribution, and recall of drugs.

(a) Order To cease distribution and recall.—Section 569D of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–8d) is amended—

(1) in the section heading, by striking “controlled substances” and inserting “drugs”;

(2) by striking “controlled substance” each place such term appears and inserting “drug”;

(3) in subsection (b)—

(A) by striking “controlled substances” and inserting “drugs”; and

(B) by inserting “of subsection (a)” after “an order pursuant to paragraph (1) or an amended order pursuant to subparagraph (B) or (C) of paragraph (3)”; and

(4) in subsection (c), by striking “or an official senior to such Director” and inserting “or the Director of the Center for Biologics Evaluation and Research (or an official senior to either such Director)”.

(b) Imports and exports.—Section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended by striking “is a controlled substance subject to an order under section 569D” and inserting “is a drug subject to an order under section 569D”.